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Accumulating evidence during the last decade established that D-serine is a key signaling
molecule utilized by neurons and astroglia in the mammalian central nervous system.
D-serine is increasingly appreciated as the main physiological endogenous coagonist for
synaptic NMDA receptors at central excitatory synapses; it is mandatory for long-term
changes in synaptic strength, memory, learning, and social interactions. Alterations in
the extracellular levels of D-serine leading to disrupted cell-cell signaling are a trademark of
many chronic or acute neurological (i.e., Alzheimer disease, epilepsy, stroke) and psychiatric
(i.e., schizophrenia) disorders, and are associated with addictive behavior (i.e., cocaine
addiction). Indeed, ﬁne tuning of the extracellular levels of D-serine, achieved by various
molecular machineries and signaling pathways, is necessary for maintenance of accurate
NMDA receptor functions. Here, we review the experimental data supporting the notion
that astroglia and neurons use different pathways to regulate levels of extracellular D-serine.
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INTRODUCTION
N-methyl D-aspartate receptors (NMDARs) are glutamate-gated
ionotropic receptors/channels that are central to many phys-
iological processes including learning and memory, and are
involved in neurotoxicity and psychiatric disorders (Traynelis
et al., 2010; Paoletti et al., 2013). In addition to glutamate,
NMDAR activation, i.e., channel opening, requires the bind-
ing of a coagonist, initially thought to be glycine (Johnson and
Ascher, 1987; Kleckner and Dingledine, 1988; Figure 1). How-
ever, many studies during the last 15 years have shown that
D-serine, an unusual amino acid synthesized in the brain by
serine racemase (SR; Campanini et al., 2013) and degraded by
the peroxysomal ﬂavoprotein D-amino acid oxidase (DAAO; Sac-
chi et al., 2012), is the main coagonist of synaptic NMDARs
in various brain areas (Martineau et al., 2006; Wolosker, 2011;
Billard, 2012; Van Horn et al., 2013). Accordingly, D-serine is
a physiological modulator of many NMDAR-dependent func-
tions, including brain development (Kim et al., 2005), synaptic
transmission and long-term synaptic plasticity (Figure 1; Mothet
et al., 2000; Yang et al., 2003; Papouin et al., 2012; Li et al., 2013;
Rosenberg et al., 2013), as well as learning, memory, and social
interactions (Labrie et al., 2008; DeVito et al., 2011). Addition-
ally, alterations in D-serine metabolism and extracellular levels
appear to be central to several pathological states. For exam-
ple, D-serine levels are greatly increased in the spinal cord of
patients with amyotrophic lateral sclerosis and a mouse model
of this disease, where it likely mediates motor neuron degen-
eration (Mitchell et al., 2010; Sasabe et al., 2012). Conversely, a
decrease of D-serine levels would be associated with the hypofunc-
tion of NMDARs in schizophrenia (Sacchi et al., 2012; Balu et al.,
2013), could be responsible for cognitive impairments observed
during healthy aging (Billard, 2012), and for the behavioral hyper-
sensitization to cocaine addiction (Curcio et al., 2013). Initially,
the effects of D-serine in the brain had been attributed solely
to its role as a gliotransmitter (Martineau et al., 2006), but this
notion has been subsequently challenged by the discovery that
D-serine is also produced and released by neurons (Wolosker
et al., 2008). Albeit the various roles have been attributed to
D-serine, the relative contribution of astrocytes and neurons in
D-serine-mediated processes are still unclear. Due to two distinct
cellular sources of this amino acid, the mechanisms underlying
D-serine dynamics and the modulation of NMDAR activity are
likely to be much more complex than previously assumed. As
excellent reviews have been recently published on the biochem-
istry of SR (Campanini et al., 2013) and DAAO (Sacchi et al.,
2012), the present review focuses primarily on the molecular
entities used by neurons and astrocytes in regulation of D-serine
functions.
NEURONAL VERSUS ASTROGLIAL D-SERINE
The biosynthesis of D-serine was clariﬁed in 1999 by the iden-
tiﬁcation of SR that converts L-serine to D-serine (Wolosker
et al., 1999). SR is a highly regulated enzyme that binds to sev-
eral receptor-interacting proteins including GRIP1 (Kim et al.,
2005), PICK1 (Hikida et al., 2008) and DISC1 (Ma et al., 2013),
while it is inhibited by nitric oxide (Mustafa et al., 2007),
palmitoylation-mediated membrane binding (Balan et al., 2009)
and phosphatidylinositol(4,5)-biphosphate (Mustafa et al., 2009).
SR knockout (SR-KO) mice exhibit less than 15% of normal
forebrain D-serine levels and altered glutamatergic neurotrans-
mission, supporting the notion that D-serine is a physiolog-
ical NMDAR coagonist (Inoue et al., 2008; Basu et al., 2009;
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FIGURE 1 | D-Serine at the tripartite synapse. L-Serine produced in
astrocytes shuttles to neurons through alanine–serine–cysteine
transporter 1 (asc-1) and fuels the synthesis of D-serine by SR. D-Serine
in turn shuttles from neurons to astrocytes, where it accumulates in glial
vesicles. Neuronal D-serine release may occur following depolarization
through asc-1, while astroglial D-serine release may occur through
exocytosis following the activation of receptors at the astrocyte plasma
membrane. Once in the synaptic cleft, D-serine binds to synaptic
NMDAR-containing GluN2A subunits. Conversely, extrasynaptic receptors
containing GluN2B preferentially bind glycine, diffusion of which towards
the cleft is prevented by GlyT1 transporters. Glycine released by neurons
through asc-1 could, however, activate synaptic NMDARs to a lesser
degree than D-serine. D-serine is ﬁnally removed from the synaptic cleft
via ASCT and asc-1 transporters. See text for details.
Horio et al., 2011). Initial studies localized D-serine and SR
predominantly in astrocytes (Schell et al., 1997; Wolosker et al.,
1999; Panatier et al., 2006) leading to the conclusion that D-
serine would be preferentially a gliotransmitter. However, the
subsequent use of new and more sensitive/speciﬁc antibod-
ies against SR and SR-KO mice as negative controls indicate
that SR prevails in excitatory and inhibitory neuronal popu-
lations throughout the brain (Kartvelishvily et al., 2006; Miya
et al., 2008; Balu et al., 2014). Additionally, the generation of
conditional cell-speciﬁc SR-KO mice reveals a lower forebrain
D-serine level along with long-term potentiation (LTP) deﬁcits
when SR gene is deleted in neurons, while deletion in astro-
cytes leads to a minimal decrease in forebrain SR expression
and no signiﬁcant change in D-serine level and NMDAR activ-
ity (Benneyworth et al., 2012). Although neuronal SR-KO mice
showed a strong reduction in SR expression in the forebrain
they exhibit only a moderate decrease in D-serine level sup-
porting the notion that peripheral (i.e., non-brain) sources
may also provide for D-serine in the brain (Benneyworth et al.,
2012).
Although neurons may appear to be the primary source of
D-serine in the brain, this does not imply that astrocytes have
only a minor role in D-serine mediated functions. In many
brain regions, astrocytic D-serine is more abundant than neu-
ronal D-serine (Kartvelishvily et al., 2006; Williams et al., 2006;
Martineau et al., 2013 but see Balu et al., 2014). If neurons
are the major source of de novo D-serine synthesis by SR,
how would then D-serine be more abundant in astrocytes?
The answer to this question may be provided by the elegant
hypothesis of a serine shuttle between neurons and astrocytes
(Wolosker, 2011). Namely, neuronal D-serine depends on the
production of L-serine by astrocytes because of the virtually
exclusive astrocytic localization of 3-phosphoglycerate dehydro-
genase which catalyzes the production of L-serine from glucose
(Yamasaki et al., 2001; Yang et al., 2010; Ehmsen et al., 2013).
L-serine is then exported and shuttles to neurons to fuel the
synthesis of D-serine by SR. D-serine is, in turn, released by
neurons and accumulates back in astrocytes, where it is stored
and released upon stimulation of astrocytes (Wolosker, 2011;
Figure 1).
The notion that D-serine is a gliotransmitter is reinforced by
many studies investigating its functions in synaptic transmission
and plasticity. In an early study, LTP was evoked in cultured hip-
pocampal neurons when they were co-cultured with astrocytes
or supplemented with exogenous D-serine (Yang et al., 2003). In
line with these data, the disruption of glial metabolism by the
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toxin ﬂuoroacetate, in acute slice preparations of the medial
prefrontal cortex or of the hippocampus, impaired NMDAR-
mediated synaptic transmission and LTP induction by reducing
the extracellular levels of D-serine (Henneberger et al., 2010;
Fossat et al., 2012). The contribution of astroglial D-serine to
activity-induced synaptic plasticity was further supported in a
physiological model of astroglia-neuron structural plasticity in the
hypothalamus (Panatier et al., 2006). Here, during lactation, the
degree of astrocytic coverage of neuronal synapses decreased lead-
ing to a reduction in NMDAR-dependent synaptic transmission
and the abolition of LTP. This phenotype was fully reversible when
D-serine levels were exogenously restored. Conversely, lowering
D-serine levels reduced synaptic transmission in virgin animals.
These studies seem to establish the contribution of astroglia as
the main source of D-serine supply for synaptic activity. This is
further evidenced by the elegant study using a mouse model for
the selective and inducible expression of a human mutant form
of DISC1 in astrocytes (Ma et al., 2013). Mutant DISC1 does not
bind SR and its expression down-regulates endogenous DISC1
leading to increasedubiquitination anddegradationof SR in astro-
cytes and thus to reduced production of astroglial D-serine and to
behavioral abnormalities consistent with hypofunction of NMDA
neurotransmission.
Of course, neuron-derived D-serine takes part in NMDAR-
mediated synaptic transmission and plasticity. Stimulation of
D-serine release speciﬁcally and exclusively from neurons has been
shown to enhance LTP in rat and mouse hippocampal slices
(Rosenberg et al., 2013). Also, a conditional deletion of SR gene in
neurons lead to reduced dendritic arborization and spine density
of pyramidal neurons of the somatosensory cortex, supporting
a major role of neuronal D-serine over astroglial D-serine in this
process (Balu and Coyle, 2012). Because D-serine dynamics are
intermingled between neurons and astrocytes, any clear conclu-
sion about the role of each source is difﬁcult to draw, regardless of
the available cell-speciﬁc genetic tools and metabolic poisoning.
The cellular origin of D-serine, neuronal versus glial, could reﬂect
upon adaptive mechanisms at individual or groups of synapses
according to speciﬁc spatio-temporal dynamics and metabolic
needs. This could be especially important in development given
that D-serine metabolism is developmentally regulated (Puyal
et al., 2006; Dun et al., 2008). It is already present during the ﬁrst
postnatal week (Kartvelishvily et al., 2006; Miya et al., 2008), yet,
most glial cells in rodents, produced after birth, increase their
number by sixfold to eightfold within the ﬁrst three postnatal
weeks (Bandeira et al., 2009; Ge et al., 2012) to establish appro-
priate astrocytic and neuronal network architectures. Although
a signiﬁcant number of astrocytes are largely generated during
the ﬁrst postnatal week, the ﬁne processes of astrocytes that con-
tact synapses in adulthood are not formed until several weeks
later (Yang et al., 2013). The astroglial network, indicated by the
interacting processes is also formed at later developmental stages
(postnatal day 14–26). Thus, it is possible that neuronal and glial
D-serine display differential onset during postnatal development.
Accordingly,we canpostulate that neuronal D-serinewill ﬁrst enter
on stage and maintained during postnatal development and adult-
hood while glial D-serine would become available after the third
postnatal week.
RELEASE MECHANISMS OF D-SERINE
As shown so far, D-serine can behave as a neurotransmitter and
a gliotransmitter in the same area of the brain. The accurate
NMDARactivation requires reliable and cell-speciﬁc releasemech-
anisms depending on the physiological or pathological condition
faced by the neuronal network. Different elements of the litera-
ture support the notion that neurons and astroglia use different
molecular machinery and signaling pathways to release D-serine
into the extracellular space (Figures 1 and 2).
The release of D-serine by astrocytes is mainly dependent
on an increase in cytosolic Ca2+ and on SNARE (soluble
N-ethylmaleimide-sensitive factor attachment protein receptor)
proteins, indicating Ca2+-regulated exocytosis as a release mecha-
nism. Indeed, disrupting Ca2+ signaling inside astrocytes reduces
D-serine release not only from astrocytes in culture and in hip-
pocampal slices (Mothet et al., 2005; Henneberger et al., 2010;
Shigetomi et al., 2013), but also from astrocytes in vivo (Takata
et al., 2011). Calcium certainly represents the most critical signal-
ing aspect of D-serine release from astrocytes, even though the
spatial and temporal dynamics of Ca2+ signals are still poorly
deﬁned. Several studies have provided evidence that the acti-
vation of glutamatergic and other G-protein coupled receptors
(GPCR; see below) triggers the release of D-serine from astro-
cytes in culture and in brain slices. The activation of the GPCRs
is associated with the recruitment of Ca2+ from the intracellu-
lar stores mainly via inositol-1,4,5-trisphosphate receptors (IP3R)
located on the endoplasmic reticulum (ER; Zorec et al., 2012); the
store is ﬁlled by the store-speciﬁc Ca2+-ATPase (SERCA). Elec-
tron and ﬂuorescence microscopy analyses report that the ER is
found beneath astrocytic plasma membrane, in close proximity
to vesicles (Marchaland et al., 2008; Bergersen et al., 2012). Astro-
cytes appear to possess functional domains where Ca2+ increase
occurs in spatial and temporal correlation with vesicular fusion
events (Marchaland et al., 2008) allowing release of gliotransmit-
ters. Although the ER and IP3Rs may provide the main route
for Ca2+ signals, other intracellular organelles and receptors such
as mitochondria and ryanodine receptors of the ER could also
be involved in the build-up of cytosolic Ca2+ concentration that
governs exocytotic D-serine release (Zorec et al., 2012). Indeed,
mitochondria are involved in the Ca2+ signaling necessary for
glial glutamate release (Reyes and Parpura, 2008) through the cal-
cium uniporter, mitochondrial Na+/Ca2+ exchanger (Reyes and
Parpura, 2008; Parnis et al., 2013) and mitochondrial permeabil-
ity transition pore/cyclophilinD (Reyes and Parpura, 2008; Reyes
et al., 2011). However, the involvement of mitochondrial Ca2+
signaling in the release of D-serine has not been shown. Ca2+
driving D-serine release could also come from the extracellular
space through channel-mediated transmembrane Ca2+ ﬂuxes in
astrocytes. Astrocytic transient receptor potential A1 (TRPA1)
channels contribute to basal Ca2+ signals which are required for
D-serine release and can modulate LTP (Shigetomi et al., 2013;
Figure 2).
Early studies have shown that D-serine release is triggered by
agonists of the ionotropic and metabotropic glutamate recep-
tors (iGluR and mGluR, respectively; Schell et al., 1995; Mothet
et al., 2005; Martineau et al., 2008). More recent studies have
now shown that many receptors for different neuroligands are
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FIGURE 2 | Cell-type specific, neuronal and astroglial, stimuli, and
mechanisms of D-serine release. Following depolarization, neurons release
D-serine from the cytosol through the transporter asc-1. Note that neuronal
depolarization is shown by the action potential discharges (utmost left).
Astrocytes express a plethora of functional receptors, the activation of
which is coupled to the release of D-serine. In many cases this would
include a downstream activation of phospholipase C (PLC). Astrocytes
release D-serine through Ca2+- and SNARE-dependent exocytosis along
with that ocurring through alternative non-exocytotic pathways including
volume-regulated anion channels (VRAC), ASCT, and likely through connexin
43 hemichannels (Cx43). The release of glial D-serine by exocytosis requires
its uptake into glial secretory vesicles. The vesicular D-serine transporter is
proposed to be a D-serine/chloride co-transporter. A spatial association of
SR activity and D-serine vesicular transport results in a local and functional
efﬁcient coupling between D-serine synthesis and uptake. See text for
details.
coupled to the release of D-serine from astroglia (Figure 2).
Accordingly, the activation of receptors for transforming growth
factor (TGF)-β (TGFR; Diniz et al., 2012), bradykinin-type2
(B2R; Martineau et al., 2008), adenosine-type 2 (A2R; Scianni
et al., 2013), ephrinB3 (Zhuang et al., 2010), and muscarinic or
nicotinic acetylcholine receptors (mAChR and nAChR, respec-
tively; Takata et al., 2011; López-Hidalgo et al., 2012; Lin et al.,
2014) triggers the release of D-serine from astrocytes, as demon-
strated using cultured astrocytes, and more intact preparations
of brain slices or live animals. These studies clearly estab-
lished that astrocytes express a plethora of functional receptors
which activation is coupled to the release of D-serine; in many
cases this includes a downstream activation of phospholipase
C (PLC; Figure 2). Taken together, various molecular entities
on the ER and the plasma membrane seem to provide for a
complex astroglial Ca2+ excitability which can trigger D-serine
release.
Fusion of vesicles with the plasma membrane is promoted
by the formation of the SNARE complex which spans the vesi-
cle and plasma membranes (Jahn and Fasshauer, 2012). The
astroglial vesicle membrane contains synaptobrevin 2 (Sb2) and
its homologue cellubrevin, either of which form the ternary
SNARE complex with synaptosome-associated protein of 23 kDa
(SNAP23) and syntaxin 1 present at the plasma membrane
(reviewed in Montana et al., 2006). The vesicle fusion is trig-
gered by an increase in cytosolic Ca2+, which presumably binds to
vesicular synaptotagmins (Montana et al., 2006). Astroglial vesi-
cles also possess proteins necessary for vesicular ﬁlling, such as
the vacuolar type H+-ATPase (V-ATPase; Wilhelm et al., 2004;
Martineau et al., 2013) which provides the proton gradient neces-
sary for intravesicular loading of gliotransmitters via appropriate
transporter(s). Cleavage of Sb2 and cellubrevin by tetanus neu-
rotoxin causes a strong inhibition of Ca2+-dependent D-serine
release (Mothet et al., 2005; Henneberger et al., 2010). Addition-
ally, the blockade of D-serine vesicular uptake using a V-ATPase
blocker inhibits D-serine release from astrocytes (Mothet et al.,
2005). Indeed, based on electron microscopy (EM), D-serine
accumulates in clear vesicles with a diameter of 36 nm in the
perisynaptic processes of hippocampal and cortical astrocytes
(Bergersen et al., 2012; Martineau et al., 2013). In the adult hip-
pocampus, clear vesicles are organized in small groups of 2–15
vesicles preferentially located within 100 nm from the astrocytic
plasma membrane (Bergersen et al., 2012), and observed at sites
adjacent to neuronal elements bearing NMDARs (Bezzi et al.,
2004). Thus, astrocytes possess small vesicles resembling those
found at synaptic terminals (Harris and Sultan, 1995), albeit at
lower density. It should be noted, however, that the vesicular
size in astrocytes appears to be more diverse than that described
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in neurons, as Sb2-laden vesicles in live cultured astrocytes have
been measured at ∼300 nm (Malarkey and Parpura, 2011; Singh
et al., 2014). In addition to Ca2+- and SNARE-dependent exo-
cytotic release of D-serine from astrocytes, this gliotransmitter
can be released via alternative non-exocytotic conduits at the
plasma membrane, including volume-regulated anion channels
(VRAC; Rosenberg et al., 2010), alanine–serine–cysteine trans-
porter (ASCT; Ribeiro et al., 2002, but see Maucler et al., 2013) and
likely through connexin 43 hemichannels (Stehberg et al., 2012;
Figure 2).
Although the vesicular transporter for D-serine has not been
identiﬁed, the transport of D-serine inside astroglial vesicles was
recently characterized (Martineau et al., 2013). While glutamate
transport is observed in both synaptic and astroglial vesicles,
the transport of D-serine is speciﬁc to astroglial vesicles (Mar-
tineau et al., 2013). Its apparent afﬁnity is ∼7 mM, consistent
with the afﬁnity of vesicular inhibitory amino acid transporter for
γ-aminobutyric acid, another neutral amino acid (Edwards, 2007;
Martineau et al., 2013). Similar to glutamate, extravesicular chlo-
ride concentration modulates D-serine transport into astroglial
vesicles, reaching the maximum activity at 4 mM. Because D-
serine transport induces vesicular acidiﬁcation and critically relies
on chloride, the vesicular D-serine transporter is proposed to
be a D-serine/chloride co-transporter (Martineau et al., 2013;
Figure 2). A spatial association of SR activity and D-serine vesic-
ular transport was observed, resulting in a functional coupling
between D-serine synthesis and uptake (Martineau et al., 2013).
Finally, D-serine and glutamate vesicular loading exert a mutual
stimulation which indicates a functional crosstalk between the
two transporters (Martineau et al., 2013). This synergy at vesicu-
lar level can only be explained if both transporters reside on the
same vesicle, indicating the co-storage and thus the co-release of
both gliotransmitters. However, the immunogold colabeling of
D-serine and glutamate in the adult hippocampus did not reveal
a population of vesicles containing both gliotransmitters (Berg-
ersen et al., 2012); this seemingly disparate ﬁndings could be a
result of the limited sensitivity of the immuno-EM. Nonethe-
less, the mechanism underlying the vesicular synergy between
D-serine and glutamate uptake requires additional investigation.
The possible co-storage of glutamate and D-serine, at least in a
subpopulation of astroglial vesicles, points to the possibility of
interdependence of their dynamics and modulatory functions at
synaptic and extrasynaptic sites.
Release of D-serine as a neurotransmitter operates through
a different mechanism than those described for a gliotransmit-
ter. Consistent with D-serine absence in the lumen of synaptic
vesicles (Martineau et al., 2013), D-serine is released by neuronal
presynaptic elements from a cytosolic pool through the alanine–
serine–cysteine transporter 1 (asc-1; Rosenberg et al., 2010, 2013;
Figures 1 and 2). Asc-1 is a Na+-independent antiporter restricted
to neurons which catalyzes neutral amino-acid hetero-exchange
(Fukasawa et al., 2000; Nakauchi et al., 2000; Helboe et al., 2003;
Matsuo et al., 2004),meaning that the release of D-serine is coupled
to the uptake of another neutral amino acid. It is the main plasma
membrane transporter mediating D-serine uptake (Rutter et al.,
2007; and see the next heading of this review) in the post-synaptic
neuronal elements (Figure 1).
Neuronal D-serine is mainly released in response to depolar-
ization, induced by veratridine, a voltage-dependent Na+-channel
activator, or by increased extracellular potassium concentration,
both in vitro and in vivo (Rosenberg et al., 2010; Figure 2).
Depolarization of cortical neurons induces a release of D-
serine ten times more effectively than the glutamatergic AMPA
(α-amino-3-hydroxy-5-methyl-isoxazole propionate) receptor
activation (Rosenberg et al., 2010). Chelation of intracellular
and extracellular Ca2+ does not affect depolarization-elicited D-
serine release. In addition, inhibition of V-ATPase by baﬁlomycin
A1 or cleavage of Sb2 by tetanus neurotoxin failed to inhibit
D-serine release from neurons, excluding the vesicular release
mechanism (Rosenberg et al., 2010). Finally, neuronal D-serine
release elicited by addition of neutral amino acids, such as D-
alanine or D-isoleucine, was independent of Na+ (Rosenberg
et al., 2010, 2013), arguing for a hetero-exchange through asc-1,
the only known Na+-independent D-serine transporter. Interest-
ingly, D-isoleucine selectively interactswith asc-1without affecting
the Na+-dependent D-serine transporters ASCT1 and ASCT2 in
HEK293 cells transfected to express various transporters (Rosen-
berg et al., 2013). The contribution of asc-1 was further con-
ﬁrmed by its inhibition with S-methyl-L-cysteine, which impaired
D-serine release evoked by L-serine; however, L-asparagine, a sub-
strate of ASCT2, did not induce D-serine release in vivo (Maucler
et al., 2013).
CONTROL OF EXTRACELLULAR D-SERINE CONCENTRATION
Concentration of extracellular D-serine is affected by two types
of antiporters: the Na+-dependent ASCT1 and ASCT2 (Ribeiro
et al., 2002; Maucler et al., 2013), and the already discussed Na+-
independent asc-1 (Rutter et al., 2007; Rosenberg et al., 2013).
These antiporters mediate the hetero-exchange of small neutral
amino acids and ﬁnely regulate D-serine concentration in the
extracellular space (Figure 1).
ASCT1 and ASCT2 (also known as SATT and AAAT; prod-
ucts of SLC1A4 and SLC1A5 genes, respectively) are members of
the alanine–serine–cysteine (ASC) family of Na+-dependent sub-
strate exchangers (see Kanai et al., 2013 for review). These two
ASC family members show highest afﬁnity for L-alanine, L-serine,
L-cysteine, and L-threonine, and stereoselectivity for L- over D-
amino acids (Arriza et al., 1993; Utsunomiya-Tate et al., 1996).
Additionally, ASCT2 transports L-glutamine and L-asparagine
with high afﬁnity (Utsunomiya-Tate et al., 1996). ASCT1/2 are
both expressed in astrocytes and neurons (Bröer et al., 1999;
Weiss et al., 2001; Yamamoto et al., 2003, 2004; Gliddon et al.,
2009; Shao et al., 2009). ASCT1 appears to be the predominant
system for uptake of L-serine in cultured neurons (Yamamoto
et al., 2004). Despite their low afﬁnity for D-serine (Arriza et al.,
1993; Utsunomiya-Tate et al., 1996), a transporter with speciﬁci-
ties resembling that of ASCTs was shown to be responsible for
D-serine uptake in cultured neurons and astrocytes (Ribeiro et al.,
2002; Shao et al., 2009), and also in vivo (Maucler et al., 2013).
Because an early study found that ASCT1 practically does not rec-
ognize D-serine (Shafqat et al., 1993), the uptake of this amino acid
was assumed to be mediated by ASCT2. However, the recent over-
expression of ASCT1 and ASCT2 in HEK293 cells showed similar
D-serine uptake for both transporters (Rosenberg et al., 2013).
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Asc-1 (encoded by SLC7A10 gene) is a member of the SCL7
solute carrier family (see Fotiadis et al., 2013 for review). As
indicated earlier, asc-1 is a Na+-independent antiporter allow-
ing permeation of small neutral amino acids such as glycine,
L-alanine, L-serine, L-threonine, and L-cysteine with high afﬁn-
ity (Fukasawa et al., 2000; Nakauchi et al., 2000). Contrary to
ASCTs, asc-1 displays a low stereospeciﬁcity and also transports
small neutral D-amino acids, in particular D-serine with a high
afﬁnity (Km ∼50 μM; Fukasawa et al., 2000). Asc-1 operates pref-
erentially in an exchange mode, but can also work as a facilitative
diffuser (Fukasawa et al., 2000; Rosenberg et al., 2013). Asc-1 is
widely expressed in the brain, being restricted to neuronal struc-
tures (Helboe et al., 2003; Matsuo et al., 2004; Shao et al., 2009).
Genetic ablation of asc-1 in mice results in a 70–80% reduction in
the D-serine uptake in the forebrain and cerebellar synaptosomes,
indicating that asc-1 is the main plasma membrane D-serine trans-
porter (Rutter et al., 2007). These asc-1 knockout mice exhibited
tremor, seizures, and early postnatal death consistent with the
over-activation of NMDARs due to elevated extracellular D-serine
levels (Xie et al., 2005). Because more speciﬁc glycine transporters
(GlyTs) exist (Eulenburg et al., 2005), asc-1 is expected to affect
to a lesser extent extracellular glycine levels. Asc-1 plays a crit-
ical role in the extracellular disposition of D-serine and in the
regulation of neuronal excitability. Yet, it is not clear how asc-
1 and ASCT1/2 transporters are working together to constraint
extracellular D-serine diffusion and how they would represent a
diffusion barrier that determines the occupancy of NMDARs by
D-serine.
SPATIAL AND TEMPORAL CONSTRAINTS OF D-SERINE
FUNCTION
Neuronal D-serine as well as glycine can be released by asc-1 upon
applicationof neutral aminoacids such asD-isoleucine (Rosenberg
et al., 2010, 2013). Interestingly, D-isoleucine mimics the activa-
tion of asc-1 by physiological extracellular substrates (L-alanine,
L-serine, and L-cysteine) present in the brain (Rosenberg et al.,
2013). Thus, the neuronal release pathway could be responsible
for setting a basal D-serine concentration in the extracellular space
over a slow time scale and large, if not global, brain volume, and,
thus, allowing for basal NMDAR activity. In stark contrast, exo-
cytosis of D-serine from astrocytes could provide for higher focal
D-serine concentration on a shorter time scale, allowing for a pre-
cise spatial and temporal boost in NMDAR activation (Figure 1).
However, it is still unknown whether D-serine is released by astro-
cytes as well as neurons at specialized zones, and where these
zones might be located. Some inferences to the location of this
process can be drawn from electrophysiology results, however.
Recently, D-serine and glycine have been shown to activate dis-
tinct populations of NMDARs in the hippocampus, with D-serine
binding to synaptic GluN1/GluN2A-containing NMDARs and
glycine to the extrasynaptic GluN1/GluN2B-containing counter-
parts (Papouin et al., 2012). Different NMDAR populations may
trigger different forms of plasticity (Liu et al., 2004). Accord-
ingly, D-serine depletion blocked LTP induction while long-term
depression (LTD) required both glycine and D-serine (Papouin
et al., 2012). The regional occupancy of NMDARs by the coago-
nists matches the preferential afﬁnity of synaptic NMDARs for
D-serine and extrasynaptic NMDARs for glycine. However, it
is not known which release/uptake mechanisms provided this
functional compartmentalization and how glutamate may acti-
vate extrasynaptic sites together with glycine. Because the level
of D-serine vary across brain regions (Schell et al., 1997), the
relative contribution of the different coagonists is likely to be
heterogeneous throughout the brain. Accordingly, different con-
temporary studies challenge the appealing model of exclusive roles
of D-serine and glycine at synaptic and extrasynaptic NMDARs,
respectively. Indeed, both neuronal D-serine and glycine released
through asc-1 were overlapping to regulate the NMDARs at
CA3-CA1 glutamatergic synapses (Rosenberg et al., 2013). Fur-
thermore, the identity of the coagonist of NMDAR at synapses
in the lateral nucleus of the amygdala was determined by the
level of synaptic activation (Li et al., 2013). Tonic activation of
NMDARs in the amygdala under low activity conditions was sup-
ported by ambient D-serine, whereas glycine may be released
from astrocytes in response to afferent stimulation. Strikingly,
GluN1/GluN2A/GluN2B tri-heteromers have recently emerged
as the preferentially NMDARs localized at synapses in the adult
forebrain (Soares and Lee, 2013; Hansen et al., 2014). Thus, the
nature of the coagonist may not correspond to spatial segrega-
tion of the NMDAR subunits, but could rather be determined
by synaptic inputs/afferents. Understanding the orchestration
between the different cellular sources for D-serine and unravel-
ing the location/existence of specialized release/uptake zones for
astroglial and neuronal D-serine and glycine will ultimately help
to elucidate the more precise roles of these amino acids as crit-
ical players in the NMDAR-mediated synaptic transmission and
plasticity.
CONCLUDING REMARKS AND FUTURE DIRECTIONS
Important advances have been made since the discovery of the
presence of D-serine in the brain in the early 1990s. There
has been considerable progress in our understanding of the
metabolism, and signaling pathways involving this atypical and
novel brain messenger with implications for the pathophysiology
of human diseases. Even though there have been developments
of small molecules modulating D-serine actions that could be
used soon in therapy for the treatment of cognitive deﬁcits asso-
ciated with aging, mood disorders and schizophrenia (Ferraris
and Tsukamoto, 2011; Panizzutti et al., 2014), there are still
many basic cell biology questions that remain to be answered,
e.g., how D-serine and glycine operate together at glutamater-
gic synapses. It appears as that in the brief period of about
two decades we went over the initial glycine era and then the
D-serine era to ﬁnally enter the composite era in which glycine
and D-serine can act as coagonists in NMDAR-mediated synap-
tic transmission. Such an inclusive approach holds promise
to aid unveiling the complexity of glutamatergic neuro- and
glio-transmission.
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